Literature DB >> 28647464

Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs.

Darwin J Prockop1, Joo Youn Oh2, Ryang Hwa Lee3.   

Abstract

Much of what we know about immunology suggests that little is to be gained from experiments in which human cells are administered to immunocompetent mice. Multiple reports have demonstrated that this common assumption does not hold for experiments with human mesenchymal stem/stromal cells (hMSCs). The data demonstrate that hMSCs can suppress immune responses to a variety of stimuli in immunocompetent mice by a range of different mechanisms that are similar to those employed by mouse MSCs. Therefore, further experiments with hMSCs in mice will make it possible to generate preclinical data that will improve both the efficacy and safety of the clinical trials with the cells that are now in progress.
Copyright © 2017 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  immunomodulation; mesenchymal stem cells; mesenchymal stromal cells; xenogeneic models

Mesh:

Year:  2017        PMID: 28647464      PMCID: PMC5542802          DOI: 10.1016/j.ymthe.2017.06.004

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  109 in total

1.  Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6.

Authors:  Gavin W Roddy; Joo Youn Oh; Ryang Hwa Lee; Thomas J Bartosh; Joni Ylostalo; Katie Coble; Robert H Rosa; Darwin J Prockop
Journal:  Stem Cells       Date:  2011-10       Impact factor: 6.277

2.  Mitochondrial transfer between cells can rescue aerobic respiration.

Authors:  Jeffrey L Spees; Scott D Olson; Mandolin J Whitney; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

4.  Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model.

Authors:  Brittni A Scruggs; Julie A Semon; Xiujuan Zhang; Shijia Zhang; Annie C Bowles; Amitabh C Pandey; Kathleen M P Imhof; Allan V Kalueff; Jeffrey M Gimble; Bruce A Bunnell
Journal:  Stem Cells Transl Med       Date:  2013-09-09       Impact factor: 6.940

5.  Comparative Efficacies of Long-Term Serial Transplantation of Syngeneic, Allogeneic, Xenogeneic, or CTLA4Ig-Overproducing Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Murine Systemic Lupus Erythematosus.

Authors:  Eun Wha Choi; Hee Woo Lee; Il Seob Shin; Ji Hyun Park; Tae Won Yun; Hwa Young Youn; Sung-Joo Kim
Journal:  Cell Transplant       Date:  2015-09-15       Impact factor: 4.064

6.  Mesenchymal Stem Cells Induce Suppressive Macrophages Through Phagocytosis in a Mouse Model of Asthma.

Authors:  Faouzi Braza; Stéphanie Dirou; Virginie Forest; Vincent Sauzeau; Dorian Hassoun; Julie Chesné; Marie-Aude Cheminant-Muller; Christine Sagan; Antoine Magnan; Patricia Lemarchand
Journal:  Stem Cells       Date:  2016-03-14       Impact factor: 6.277

7.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

8.  Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism.

Authors:  Anoop Babu Vasandan; Sowmya Jahnavi; Chandanala Shashank; Priya Prasad; Anujith Kumar; S Jyothi Prasanna
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

9.  Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.

Authors:  D F McAuley; G F Curley; U I Hamid; J G Laffey; J Abbott; D H McKenna; X Fang; M A Matthay; J W Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-14       Impact factor: 5.464

10.  Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs.

Authors:  Donald G Phinney; Michelangelo Di Giuseppe; Joel Njah; Ernest Sala; Sruti Shiva; Claudette M St Croix; Donna B Stolz; Simon C Watkins; Y Peter Di; George D Leikauf; Jay Kolls; David W H Riches; Giuseppe Deiuliis; Naftali Kaminski; Siddaraju V Boregowda; David H McKenna; Luis A Ortiz
Journal:  Nat Commun       Date:  2015-10-07       Impact factor: 14.919

View more
  16 in total

1.  Programmable microencapsulation for enhanced mesenchymal stem cell persistence and immunomodulation.

Authors:  Angelo S Mao; Berna Özkale; Nisarg J Shah; Kyle H Vining; Tiphaine Descombes; Liyuan Zhang; Christina M Tringides; Sing-Wan Wong; Jae-Won Shin; David T Scadden; David A Weitz; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-16       Impact factor: 11.205

2.  Mesenchymal stromal cells induce distinct myeloid-derived suppressor cells in inflammation.

Authors:  Hyun Ju Lee; Jung Hwa Ko; Hyeon Ji Kim; Hyun Jeong Jeong; Joo Youn Oh
Journal:  JCI Insight       Date:  2020-06-18

3.  MHC Class I Enables MSCs to Evade NK-Cell-Mediated Cytotoxicity and Exert Immunosuppressive Activity.

Authors:  Joo Youn Oh; Hyemee Kim; Hyun Ju Lee; Kangin Lee; Heather Barreda; Hyeon Ji Kim; Eunji Shin; Eun-Hye Bae; Gagandeep Kaur; Yu Zhang; Eunjae Kim; Jae Young Lee; Ryang Hwa Lee
Journal:  Stem Cells       Date:  2022-09-26       Impact factor: 5.845

4.  Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: A pre-clinical systematic review.

Authors:  Chintan Dave; Shirley H J Mei; Andrea McRae; Christine Hum; Katrina J Sullivan; Josee Champagne; Tim Ramsay; Lauralyn McIntyre
Journal:  Elife       Date:  2022-07-15       Impact factor: 8.713

Review 5.  Manufacturing of primed mesenchymal stromal cells for therapy.

Authors:  James Q Yin; Jun Zhu; James A Ankrum
Journal:  Nat Biomed Eng       Date:  2019-01-28       Impact factor: 25.671

Review 6.  Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.

Authors:  Joo Youn Oh; Ryang Hwa Lee
Journal:  Prog Retin Eye Res       Date:  2021-03-26       Impact factor: 21.198

7.  Human Mesenchymal Stem Cell-Treated Regulatory CD23+CD43+ B Cells Alleviate Intestinal Inflammation.

Authors:  Xiaoyong Chen; Chuang Cai; Dijing Xu; Qiuli Liu; Shuwei Zheng; Longshan Liu; Gang Li; Xiaoran Zhang; Xiaoping Li; Yuanchen Ma; Li Huang; Jieying Chen; Jiahao Shi; Xin Du; Wenjie Xia; Andy Peng Xiang; Yanwen Peng
Journal:  Theranostics       Date:  2019-06-24       Impact factor: 11.556

8.  The enhancement of CCL2 and CCL5 by human bone marrow-derived mesenchymal stem/stromal cells might contribute to inflammatory suppression and axonal extension after spinal cord injury.

Authors:  Kazumichi Yagura; Hirokazu Ohtaki; Tomomi Tsumuraya; Atsushi Sato; Kazuyuki Miyamoto; Naoto Kawada; Keisuke Suzuki; Motoyasu Nakamura; Koji Kanzaki; Kenji Dohi; Masahiko Izumizaki; Yutaka Hiraizumi; Kazuho Honda
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

9.  Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis.

Authors:  Pamela Sarkar; Juliana Redondo; Kevin Kemp; Mark Ginty; Alastair Wilkins; Neil J Scolding; Claire M Rice
Journal:  Cytotherapy       Date:  2017-09-13       Impact factor: 5.414

Review 10.  Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives.

Authors:  Anna Campanati; Veronica Consales; Monia Orciani; Katia Giuliodori; Giulia Ganzetti; Ivan Bobyr; Giulia Sorgentoni; Roberto di Primio; Annamaria Offidani
Journal:  Psoriasis (Auckl)       Date:  2017-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.